Live Breaking News & Updates on Mission covid suraksha

Stay informed with the latest breaking news from Mission covid suraksha on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mission covid suraksha and stay connected to the pulse of your community

Govt launches Gemovac-OM, India's first Omicron-specific mRNA booster vaccine

The vaccine has been developed using the indigenous platform technology by Gennova, with funding support from Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Counci

India , Atmanirbhar-bharat , Jitendra-singh , Development-of-the-world , Ministry-of-science-technology , Biotechnology-industry-research-assistance-council , Department-of-biotechnology , Mission-covid-suraksha , Drug-control-general , Emergency-use-authorization , Prime-minister , Gemcovac-om

Dr Jitendra Launches India's First Corona Variant Omicron Booster Vaccine

Dr Jitendra Launches India's First Corona Variant Omicron Booster Vaccine
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

India , Atmanirbhar-bharat , Narendra-modi , Jitendra-singh , Vinod-paul , Gennova-sanjay-singh , Emcure-satish-mehta , Rajesh-gokhale , Department-of-biotechnology , Department-of-atomic-energy , Mission-covid-suraksha , Development-of-the-world

Dr Jitendra Singh launches GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine

Dr Jitendra Singh launches GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine
pragativadi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pragativadi.com Daily Mail and Mail on Sunday newspapers.

New-delhi , Delhi , India , Jitendra-singh , Atmanirbhar-bharat , Narendra-modi , Development-of-the-world , Biotechnology-industry-research-assistance-council , Department-of-space , Department-of-atomic-energy , Mission-covid-suraksha , National-biopharma-mission

Minister Dr Jitendra Singh launches the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine

Minister Dr Jitendra Singh launches the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine
orissadiary.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissadiary.com Daily Mail and Mail on Sunday newspapers.

India , Atmanirbhar-bharat , Jitendra-singh , Narendra-modi , Indo-us-vaccine-action-programme , Biotechnology-industry-research-assistance-council , Department-of-biotechnology , Mission-covid-suraksha , Department-of-space , Department-of-atomic-energy , Development-of-the-world , National-biopharma-mission

Omicron: Drug controller gives emergency-use approval to booster vaccine for Omicron variant | India News

India News: NEW DELHI: India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Gennova Bi.

India , Wuhan , Hubei , China , Jitendra-singh , Sanjay-singh , Rajeshs-gokhale , Indian-covid , Gennova-biopharmaceuticals-ltd , Gennova-biopharmaceuticals-under-mission-covid-suraksha , Mission-covid-suraksha , Department-of-biotechnology

Booster Vaccine For Omicron Variant Gets Emergency Use Approval

It is a thermostable vaccine, which does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines, , booster vaccine, Omicron variant, Emergency use approval, Omicron, COVID-19

India , Ministry-of-science , Biotechnology-industry-research-assistance-council , Mission-covid-suraksha , Drug-control-general , Gennova-biopharmaceuticals ,

Drug controller's nod for Omicron-specific mRNA-based vaccine

India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Genova.

India , Wuhan , Hubei , China , New-delhi , Delhi , Indian-covid , Sanjay-singh , Rajeshs-gokhale , Jitendra-singh , Genova-biopharmaceuticals-under-mission-covid-suraksha , Mission-covid-suraksha

Govt Gives Nod For Covid-19 Omicron-Specific mRNA-Based Vaccine

Govt Gives Nod For Covid-19 Omicron-Specific mRNA-Based Vaccine
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.

Wuhan , Hubei , China , India , Sanjay-singh , Indian-covid , Rajeshs-gokhale , Jitendra-singh , Gennova-biopharmaceuticals-ltd , Mission-covid-suraksha , Vaccine-development-mission , Department-of-biotechnology

India's first mRNA-based Omicron-specific booster vaccine from Pune-based Gennova gets DCGI approval

Gennova Biopharmaceuticals' mRNA Covid-19 booster vaccine, 'Gemcovac Om', has received emergency use authorisation from the office of the Drugs Controller General of India for the Omicron variant. The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant and has demonstrated robust immune responses in phase 3 clinical trials. It is stable at two to eight degrees Centigrade and has been developed using Gennova's indigenous platform technology, supported under 'Mission Covid Suraksha'.

India , Pune , Maharashtra , Wuhan , Hubei , China , Sanjay-singh , Samit-mehta , Indian-covid , A-press-information-bureau , Gennova-biopharmaceuticals-ltd , Mission-covid-suraksha

Omicron specific mRNA-based booster vaccine approved for emergency use

New Delhi, 20 June (Hindustan Times). The Department of Biotechnology (DBT) has announced that the mRNA-based booster vaccine for the Omicron variant of | BLiTZ

India , New-delhi , Delhi , Jitendra-singh , Ministry-of-science , Mission-covid-suraksha , Department-of-biotechnology , Genova-biopharmaceuticals-ltd , Biotechnology-industry-research-assistance-council , Hindustan-times , Drug-control-general , Genova-biopharmaceuticals